morgan griffith

warning: Creating default object from empty value in /home/hemporg/public_html/news/modules/taxonomy/taxonomy.pages.inc on line 34.

U.S.: House, Senate Bills Aim To Remove Barriers To Marijuana Research

AndyHarrisSenatorMD[BillClark-RollCall].jpg

Bipartisan, Bicameral Medical Marijuana Research Legislation Introduced in House and Senate

By Steve Elliott
Hemp News

There's a major development in federal cannabis legislation this week. Congressmen Andy Harris, M.D. (R-MD), Earl Blumenauer (D-OR), H. Morgan Griffith (R-VA), and Sam Farr (D-CA) will be introducing the Medical Marijuana Research Act of 2016. This bill heeds the calls of the medical research community to address the burdensome processes that currently impede legitimate medical research on marijuana.

The bill is a bipartisan and bicameral solution that removes barriers inhibiting medical marijuana research. Senators Brian Schatz (D-HI), Orrin Hatch (R-UT), Chris Coons (D-DE), and Thom Tillis (R-NC) are introducing a similar bill in the Senate.

“As a physician who has conducted NIH sponsored research, I can’t stress enough how critical this legislation is to the scientific community," said Dr. Harris. "Our drug policy was never intended to act as an impediment to conducting legitimate medical research.

U.S.: Bipartisan Medical Efficacy of Marijuana Amendment Introduced In House

MarijuanaLeafSuitLapel

Amendment to 21st Century Cures Bill Would Encourage Marijuana Research

Republican Congressmen H. Morgan Griffith (VA-09) and Andy Harris, M.D., (MD-01), and Democratic Congressmen Sam Farr (CA-20) and Earl Blumenauer (OR-03) on Wednesday introduced the “Credible Research on Medical Efficacy of Marijuana Amendment” to the 21st Century Cures Act, or H.R. 6, which is currently scheduled to be considered on the House floor this week.

The amendment focuses on removing barriers that inhibit research on marijuana. This amendment encourages the National Institutes of Health (NIH) to work with the Drug Enforcement Administration (DEA) to initiate and collaborate on research about the medical risks and benefits of marijuana.

This does not change marijuana from a Schedule I drug, but does create a new subclassification within Schedule I – “Schedule 1R” for marijuana that would make research easier to conduct.

“There has been little research into potential therapeutic benefits and risks of medical marijuana use," said Congressman Griffith. "In many cases, research into specific relief it provides, how it can best be used, etc. has been obstructed by federal obstacles.

"This amendment is a responsible approach to increasing research and pursuing the answers to questions being asked by so many patients, doctors, researchers, and policy makers about medicinal marijuana,” said Griffith said.

Syndicate content